4 results returned.
Page of 1
Minnesota v. Sanofi-Aventis U.S. LLC
District Court: District Court of New Jersey Status: Pending
Minnesota’s attorney general filed a suit accusing Sanofi, Eli Lilly, and Novo Nordisk, the three largest manufacturers of insulin, of price gouging. The lawsuit, filed in […]
Herrera et al. v. JFK Medical Center et al.
District Court: M.D. Florida Status: Decided
In August 2014, plaintiffs filed a putative class action against multiple HCA-operated hospitals in Tampa, alleging they were charged unreasonable amounts for emergency radiological services. […]
PhRMA and BIO v. Sandoval
District Court: District of Nevada Status: Decided
In September 2017, just three months after Nevada passed its insulin transparency law (SB 539) in June 2017 to increase transparency over the price of […]
Association for Accessible Medicines v. Frosh
District Court: District of Maryland Status: Decided
In a significant victory for the pharmaceutical industry, the 4th U.S. Circuit Court of Appeals found Maryland’s landmark 2017 law (HB 631), which punishes generic […]
4 results returned.
Page of 1